Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

Chronic kidney disease (CKD) is increasingly recognized as a major global health issue, and disparities in healthcare access ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

The following is a summary of “Carotid plaque thickness predicts cardiovascular events and death in patients with chronic ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Malaysia’s total industry volume (TIV) could potentially reach up to 800,000 units this year, driven by promotion from both ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

Chronic kidney disease (CKD) affects millions worldwide, and as the demand for effective dialysis treatments grows, ...